Identification of a chemotherapeutic lead molecule for the potential disruption of the FAM72A-UNG2 interaction to interfere with genome stability, centromere formation, and genome editing
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Renganathan, Senthil | - |
dc.contributor.author | Pramanik, Subrata | - |
dc.contributor.author | Ekambaram, Rajasekaran | - |
dc.contributor.author | Kutzner, Arne | - |
dc.contributor.author | Kim, Pok-Son | - |
dc.contributor.author | Heese, Klaus | - |
dc.date.accessioned | 2022-07-06T11:35:45Z | - |
dc.date.available | 2022-07-06T11:35:45Z | - |
dc.date.created | 2022-01-05 | - |
dc.date.issued | 2021-11 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/140418 | - |
dc.description.abstract | Family with sequence similarity 72 A (FAM72A) is a pivotal mitosis-promoting factor that is highly expressed in various types of cancer. FAM72A interacts with the uracil-DNA glycosylase UNG2 to prevent mutagenesis by eliminating uracil from DNA molecules through cleaving the Nglycosylic bond and initiating the base excision repair pathway, thus maintaining genome integrity. In the present study, we determined a specific FAM72A-UNG2 heterodimer protein interaction using molecular docking and dynamics. In addition, through in silico screening, we identified withaferin B as a molecule that can specifically prevent the FAM72A-UNG2 interaction by blocking its cell signaling pathways. Our results provide an excellent basis for possible therapeutic approaches in the clinical treatment of cancer. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | Identification of a chemotherapeutic lead molecule for the potential disruption of the FAM72A-UNG2 interaction to interfere with genome stability, centromere formation, and genome editing | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kutzner, Arne | - |
dc.contributor.affiliatedAuthor | Heese, Klaus | - |
dc.identifier.doi | 10.3390/cancers13225870 | - |
dc.identifier.scopusid | 2-s2.0-85119964010 | - |
dc.identifier.wosid | 000773917700045 | - |
dc.identifier.bibliographicCitation | CANCERS, v.13, no.22, pp.1 - 19 | - |
dc.relation.isPartOf | CANCERS | - |
dc.citation.title | CANCERS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 19 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | URACIL-DNA GLYCOSYLASE | - |
dc.subject.keywordPlus | BASE EXCISION-REPAIR | - |
dc.subject.keywordPlus | PROTEIN-STRUCTURE | - |
dc.subject.keywordPlus | PHYSICAL REALISM | - |
dc.subject.keywordPlus | WEB SERVER | - |
dc.subject.keywordPlus | DOCKING | - |
dc.subject.keywordPlus | WITHAFERIN | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | ACCURACY | - |
dc.subject.keywordPlus | NUCLEAR | - |
dc.subject.keywordAuthor | Cell cycle | - |
dc.subject.keywordAuthor | Centromere | - |
dc.subject.keywordAuthor | DNA repair | - |
dc.subject.keywordAuthor | Proliferation | - |
dc.identifier.url | https://www.mdpi.com/2072-6694/13/22/5870 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.